Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€69.56

€69.56

-3.120%
-2.26
-3.120%
€124.85

€124.85

 
23.12.25 / Tradegate WKN: 529882 / Symbol: CORT / Name: Corcept / Stock / Pharmaceuticals / Small Cap /
Latest predictions
€125.79
25.11.25
0.43%
buy
€124.35
20.10.25
3.05%
buy
€125.35
10.10.25
-4.16%
buy
€128.38
06.05.25
6.56%
buy
€119.96
03.04.25
-4.92%
buy
€138.36
31.03.25
-25.76%
buy
Your prediction

Corcept Therapeutics Inc. Stock

Corcept Therapeutics Inc. took a tumble today and lost -€2.260 (-3.120%).
Corcept Therapeutics Inc. is currently one of the favorites of our community with 11 Buy predictions and no Sell predictions.
As a result the target price of 124 € shows a very positive potential of 78.26% compared to the current price of 69.56 € for Corcept Therapeutics Inc..
For the coming years our community has positive and negative things to say abot the Corcept Therapeutics Inc. stock. Criterium "Worthwhile Investment for the next years" gathered the most positive votes but regarding "Worthwhile Investment for the next years" there were negative voices in the community.

Pros and Cons of Corcept Therapeutics Inc. in the next few years

Pros
?
G***** c******* t* c**********
?
B****
?
W********* I********* f** t** n*** y****
Cons
?
S********** s********
?
C******** o* t** e**********
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'

Comments

Prediction Buy
Perf. (%) 0.43%
Target price 125.788
Change
Ends at 25.11.26

Corcept Therapeutics (NASDAQ:CORT) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $145.00 price target on the stock.
Ratings data for CORT provided by MarketBeat
Show more

Prediction Buy
Perf. (%) 3.05%
Target price 124.352
Change
Ends at 20.10.26

Corcept Therapeutics (NASDAQ:CORT) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $145.00 price target on the stock.
Ratings data for CORT provided by MarketBeat
Show more

Prediction Buy
Perf. (%) -4.16%
Target price 125.353
Change
Ends at 10.10.26

Corcept Therapeutics (NASDAQ:CORT) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $145.00 price target on the stock.
Ratings data for CORT provided by MarketBeat
Show more